Jun 5, 2024, 05:51
Francisco J. Esteva: Congratulations to Giuseppe Curigliano for the presentation of the DESTINY-Breast06 trial at ASCO24
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared on LinkedIn: .
“Congratulations to Giuseppe Curigliano for the outstanding presentation of the DESTINY-Breast06 trial at the ASCO Annual Meeting.
The improvement in progression-free survival in the group of patients treated with trastuzumab deruxtecan (T-DXd, Enhertu) compared to conventional chemotherapy is statistically significant and clinically meaningful.
Practice changing study!”
Source: Francisco J. Esteva/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 23, 2024, 07:06
Oct 23, 2024, 06:59
Oct 23, 2024, 05:24
Oct 23, 2024, 05:17
Oct 23, 2024, 05:11
Oct 23, 2024, 05:05
Oct 23, 2024, 04:41
Oct 23, 2024, 04:34
Oct 23, 2024, 04:16